The role of dietary factors in prevention and progression of breast cancer

Anticancer Research

Volumn 34, Issue 12, 2014, Pages 6861-6875

  Rossi, Roberta Elisa ^a,b   Pericleous, Marinos ^a   Mandair, Dalvinder ^a,c   Whyand, Tara ^a   Caplin, Martyn Evan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Breast cancer; Carcinogenesis; Diet; Nutrition; Prevention review.

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CARBOHYDRATE; CHOLESTEROL; ESTROGEN; FAT; FOLIC ACID; LYCOPENE; OMEGA 3 FATTY ACID; PHYTOESTROGEN; POLYCYCLIC AROMATIC HYDROCARBON; POLYPHENOL; RETINOL; TRIACYLGLYCEROL; VITAMIN; VITAMIN B GROUP; VITAMIN D; ZINC;

ALCOHOL CONSUMPTION; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CARBOHYDRATE DIET; CARBOHYDRATE INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DIETARY INTAKE; DISEASE ASSOCIATION; FISH; FRUIT; GLYCEMIC INDEX; HUMAN; LIPID DIET; META ANALYSIS (TOPIC); NONHUMAN; PATHOPHYSIOLOGY; RED MEAT; REVIEW; SYSTEMATIC REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VEGETABLE; ADVERSE EFFECTS; ANIMAL; BREAST NEOPLASMS; DIET; DISEASE COURSE; FEMALE; PATHOLOGY; STANDARDS; STATISTICS AND NUMERICAL DATA;

ANIMALS; BREAST NEOPLASMS; DIET; DISEASE PROGRESSION; FEMALE; HUMANS;

EID: 84918525672     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Review

References (175)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-69, 2011.
2. http://www.cancer.org/acs/groups/content/@epidemiology surveilance/documents/document/acspc-031941.pdf Am. Cancer Soc. (2012). Cancer Facts & Figures 2012. Atlanta, GA: Am. Cancer Soc.
3. http://www.cancer.org/Cancer/BreastCancer/OverviewGuide/breast-cancer-overview-survival-rates Am. Cancer Soc. (2011). Survival Rates for Breast Cancer. Atlanta, GA: Am. Cancer Soc.
4. Zare N, Haem E, Lankarani KB, Heydari ST and Barooti E: Breast cancer risk factors in a defined population: weighted logistic regression approach for rare events. J Breast Cancer 16: 214-219, 2013.
5. Rose DP and Vona-Davis L: Biochemical and molecular mechanisms for the association between obesity, chronic Inflammation, and breast cancer. Biofactors 40: 1-12, 2014.
6. McCullough ML and Giovannucci EL: Diet and cancer prevention. Oncogene 23: 6349-6364, 2004.
7. World Cancer Res. Fund Int./Am. Inst. Cancer Res. (2010). Continuous Update Project ReportSummary. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. London:World Cancer Res. Fund Int. http://www.dietand cancerreport.org/cancer-resource-center/cup-summaries.php
8. Tappel A: Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med Hypotheses 68: 562-564, 2007.
9. Ito N, Hasegawa R, Sano S, Tamano S, Esumi H, Takayama S and Sugimura T: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4, 5b]pyridine (PhIP). Carcinogenesis 12: 1503-1506, 1991.
10. Zheng W, Gustafson DR, Sinha R, Cerhan JR, Moore D, Hong CP, Anderson KE, Kushi LH, Sellers TA and Folsom AR: Welldone meat intake and the risk of breast cancer. J Natl Cancer Inst 90: 1724-1729, 1998.
11. Kushi LH, Sellers TA, Potter JD, Nelson CL, Munger RG, Kaye SA, Folsom AR: Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst 84: 1092-1099, 1992.
12. Knekt P, Steineck G, Jarvinen R, Hakulinen T and Aromaa A: Intake of fried meat and risk of cancer: a follow-up study in Finland. Int J Cancer 59: 756-760, 1994.
13. De Stefani E, Ronco A, Mendilaharsu M, Guidobono M and Deneo-Pellegrini H: Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 6: 573-578, 1997.
14. Ceccatto V, Cesa C, Kunradi Vieira FG, Altenburg de Assis MA, Crippa CG and Faria Di Pietro P: Characteristics of newly diagnosed women with breast cancer: a comparison with the recommendations of the WCRF/AICR Second Report. Nutr Hosp 27: 1973-1980, 2012.
15. Qureshi SA, Couto E, Hofvind S, Wu AH and Ursin G: Alcohol intake and mammographic density in postmenopausal Norwegian women. Breast Cancer Res Treat 131: 993-1002, 2012.
16. Alexander DD, Morimoto LM, Mink PJ and Cushing CA: A review and eta-analysis of red and processed meat consumption and breast cancer. Nutr Res Rev 23: 349-365, 2010.
17. Nowell SA, Ahn J and Ambrosone CB: Gene-nutrient interactions in cancer etiology. Nutr Rev 62: 427-438, 2004.
18. Taylor VH, Misra M and Mukherjee SD: Is red meat intake a risk factor for breast cancer among premenopausal women? Breast Cancer Res Treat 117: 1-8, 2009.
19. Farvid MS, Cho E, Chen WY, Eliassen AH and Willett WC: Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study. BMJ 348: g3437, 2014.
20. Karmali RA, Marsh J and Fuchs C: Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst 73: 457-461, 1984.
21. Kort WJ, Weijma IM, Bijma AM, van Schalkwijk WP, Vergroesen AJ and Westbroek DL: Omega-3 fatty acids inhibiting the growth of a transplantable rat mammary adenocarcinoma. J Natl Cancer Inst 79: 593-599, 1987.
22. Schley PD, Jijon HB, Robinson LE and Field CJ: Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 92: 187-195, 2005.
23. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP and Yu MC: Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: the Singapore Chinese Health Study. Br J Cancer 89: 1686-1692, 2003.
24. Wakai K, Tamakoshi K, Date C, Fukui M, Suzuki S, Lin Y, Niwa Y, Nishio K, Yatsuya H, Kondo T, Tokudome S, Yamamoto A, Toyoshima H and Tamakoshi A; JACC Study Group: Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci 96: 590-599, 2005.
25. Zheng JS, Hu XJ, Zhao YM, Yang J and Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 346: f3706, 2013.
26. Cho E, Spiegelman D, Hunter DJ, Chen WY, Colditz GA and Willett WC: Premenopausal dietary carbohydrate, glycemic index, glycemic load, and fiber in relation to risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12(11 Pt 1): 1153-1158, 2003.
27. Higginbotham S, Zhang ZF, Lee IM, Cook NR, Buring JE and Liu S: Dietary glycemic load and breast cancer risk in the Womens Health Study. Cancer Epidemiol Biomarkers Prev 13: 65-70, 2004.
28. Sieri S, Krogh V, Ferrari P, Berrino F, Pala V, Thiébaut AC, Tjøoneland A, Olsen A, Overvad K, Jakobsen MU, Clavel-Chapelon F, Chajes V, Boutron-Ruault MC, Kaaks R, Linseisen J, Boeing H, Nhlings U, Trichopoulou A, Naska A, Lagiou P, Panico S, Palli D, Vineis P, Tumino R, Lund E, Kumle M, Skeie G, Gonzez CA, Ardanaz E, Amiano P, Tormo MJ, Martínez-Garc C, Quir JR, Berglund G, Gullberg B, Hallmans G, Lenner P, Bueno-de-Mesquita HB, van Duijnhoven FJ, Peeters PH, van Gils CH, Key TJ, Crowe FL, Bingham S, Khaw KT, Rinaldi S, Slimani N, Jenab M, Norat T and Riboli E: Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 88: 1304-1312, 2008.
29. George SM, Mayne ST, Leitzmann MF, Park Y, Schatzkin A, Flood A, Hollenbeck A and Subar AF: Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study. Am J Epidemiol 169: 462-472, 2009.
30. Larsson SC, Bergkvist L and Wolk A: Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women. Int J Cancer 125: 153-157, 2009.
31. Wen W, Shu XO, Li H, Yang G, Ji BT, Cai H, Gao YT and Zheng W: Dietary carbohydrates, fiber, and breast cancer risk in Chinese women. Am J Clin Nutr 89: 283-289, 2009.
32. Bradshaw PT, Khankari NK, Teitelbaum SL, Xu X, Fink BN, Steck SE, Gaudet MM, Kabat GC, Wolff MS, Neugut AI, Chen J and Gammon MD: Nutrient pathways and breast cancer risk: the Long Island Breast Cancer Study Project. Nutr Cancer 65: 345-354, 2013.
33. Coulston AM, Hollenbeck CB, Swislocki AL and Reaven GM: Effect of source of dietary carbohydrate on plasma glucose and insulin responses to mixed meals in subjects with NIDDM. Diabetes Care 10: 395-400, 1987.
34. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P and Brand-Miller JC: Glycemic index, glycemic load, and chronic disease risk-A meta-analysis of observational studies. Am J Clin Nutr 87: 627-637, 2008
35. Mulholland HG, Murray LJ, Cardwell CR and Cantwell MM: Dietary glycaemic index, glycaemic load and breast cancer risk: A systematic review and meta-analysis. Br J Cancer 99: 1170-1175, 2008.
36. Shikany JM, ReddenDT, Neuhouser ML, Chlebowski RT, Rohan TE, Simon MS, Liu S, Lane DS and Tinker L: Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the womens health initiative. Nutr Cancer 63: 899-907, 2011.
37. Kaaks R and Lukanova A. Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc 60: 91-106, 2001.
38. Schernhammer ES, Holly JM, Pollak MN, and Hankinson SE: Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14: 699-704, 2005.
39. Werner H and LeRoith D: The role of the insulin-like growth factor system in human cancer. Adv Cancer Res 68: 183-223, 1996.
40. Paolisso G, Scheen A, DOnofrio F and Lefvebre P: Magnesium and glucose homeostasis. Diabetologia 33: 511-514, 1990.
41. Rungby J: Zinc, zinc transporters and diabetes. Diabetologia 53: 1549-1551, 2010
42. Rutter GA, Tsuboi T and Ravier MA: Ca2+ microdomains and the control of insulin secretion. Cell Calcium 40: 539-551, 2006.
43. Sieri S, Pala V, Brighenti F, Agnoli C, Grioni S, Berrino F, Scazzina F, Palli D, Masala G, Vineis P, Sacerdote C, Tumino R, Giurdanella MC, Mattiello A, Panico S and Krogh V: High glycemic diet and breast cancer occurrence in the Italian EPIC cohort. Nutr Metab Cardiovasc Dis 23: 628-634, 2013.
44. Hunter DJ and Willett WC: Diet, body size, and breast cancer. Epidemiol Rev 15: 110-132, 1993.
45. Fay MP, Freedman LS, Clifford CK and Midthune DN: Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res 57: 3979-3988, 1997.
46. Prentice RL and Sheppard L: Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes Control 1: 81-97, 1990.
47. Boyd NF, Martin LJ, Noffel M, Lockwood GA and Trichler DL: A meta-analysis of studies of dietary fat and breast cancer risk. Br J Cancer 68: 627-636, 1993.
48. Thiebaut AC, Kipnis V, Chang SC, Subar AF, Thompson FE, Rosenberg PS, Hollenbeck AR, Leitzmann M and Schatzkin A: Dietary fat and postmenopausal invasive breast cancer in the National Institutes of Health-AARP Diet and Health Study cohort. J Natl Cancer Inst 99: 451-462, 2007.
49. Smith-Warner SA, Spiegelman D, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Kushi LH, Miller AB, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A and Hunter DJ: Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer 92: 767-774, 2001.
50. Alexander DD, Morimoto LM, Mink PJ and Lowe KA: Summary and meta-analysis of prospective studies of animal fat intake and breast cancer. Nutr Res Rev 23: 169-179, 2010.
51. Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, Shikany JM, Stefanick ML, Thomson CA, Van Horn L, Vitolins MZ, Wactawski-Wende J, Wallace RB, Wassertheil-Smoller S, Whitlock E, Yano K, Adams-Campbell L, Anderson GL, Assaf AR, Beresford SA, Black HR, Brunner RL, Brzyski RG, Ford L, Gass M, Hays J, Heber D, Heiss G, Hendrix SL, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Kotchen JM, LaCroix AZ, Lane DS, Langer RD, Lasser NL and Henderson MM: Low-fat dietary pattern and risk of invasive breast cancer: the Womens Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 295: 629-642, 2006.
52. Wang J, John EM, Horn-Ross PL and Ingles SA: Dietary fat, cooking fat, and breast cancer risk in a multiethnic population. Nutr Cancer 60: 492-504, 2008.
53. Sugimura T: Nutrition and dietary carcinogens. Carcinogenesis 21: 387-395, 2000.
54. Blackburn GL and Wang KA: Dietary fat reduction and breast cancer outcome: results from the Womens Intervention Nutrition Study (WINS). Am J Clin Nutr 86: s878-881, 2007.
55. Ray G and Husain SA: Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34: 71-76, 2001.
56. Franky Dhaval S, Shilin Nandubhai S, Pankaj Manubhai S, Patel HR and Prabhudas Shankerbhai Patel: Significance of alterations in plasma lipid profile levels in breast cancer. Integr Cancer Ther 7: 33-41, 2008.
57. Owiredu WK, Donkor S, Addai BW and Amidu N: Serum lipid profile of breast cancer patients. Pak J Biol Sci 12: 332-338, 2009.
58. Abu-Bedair FA, El-Gamal BA, Ibrahim NA and El-Aaser AA: Serum lipids and tissue DNA content in Egyptian female breast cancer patients. Jpn J Clin Oncol 33: 278-282, 2003.
59. Kapil U, Bhadoria AS, Sareen N, Singh P and Dwivedi SN: Total cholesterol and triglyceride levels in patients with breast cancer. J Breast Cancer 16: 129-130, 2013.
60. Makarem N, Chandran U, Bandera EV and Parekh N: Dietary fat in breast cancer survival. Annu Rev Nutr 33: 319-348, 2013.
61. Sieri S, Chiodini P, Agnoli C, Pala V, Berrino F, Trichopoulou A, Benetou V, Vasilopoulou E, Sánchez MJ, Chirlaque MD, Amiano P, Quiros JR, Ardanaz E, Buckland G, Masala G, Panico S, Grioni S, Sacerdote C, Tumino R, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Peeters PH, van Gils CH, Bueno-de-Mesquita HB, van Kranen HJ, Key TJ, Travis RC, Khaw KT, Wareham NJ, Kaaks R, Lukanova A, Boeing H, Schze M, Sonestedt E, Wirfält E, Sund M, Andersson A, Chajes V, Rinaldi S, Romieu I, Weiderpass E, Skeie G, Dagrun E, Tjøoneland A, Halkjær J, Overvard K, Merritt MA, Cox D, Riboli E and Krogh V: Dietary fat intake and development of specific breast cancer subtypes. J Natl Cancer Inst 106. pii: dju068. doi: 10.1093/jnci/dju068, 2014.
62. Cazarolli LH, Zanatta L, Alberton EH, Figueiredo MS, Folador P, Damazio RG, Pizzolatti MG and Silva FR: Flavonoids: prospective drug candidates. Mini Rev Med Chem 8: 1429-1240, 2008.
63. Adolphe JL, Whiting SJ, Juurlink BH, Thorpe LU and Alcorn J: Health effects with consumption of the flax lignan secoisolariciresinol diglucoside. Br J Nutr 103: 929-938, 2010.
64. Rice S and Whitehead SA: Phytoestrogens oestrogen synthesis and breast cancer. J Steroid Biochem Mol Biol 108: 186-195, 2008.
65. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z and Mantian M: Flavonoids, flavonoid subclasses and breast cancer risk: a metaanalysis of epidemiologic studies. PLoS One 8: e54318, 2013.
66. Knekt P, Jarvinen R, Seppanen R, Hellaara M, Teppo L, Pukkala E and Aromaa A: Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146: 223-230, 1997.
67. Knekt P, Kumpulainen J, Jarvinen R, Rissanen H, Heliaara M, Reunanen A, Hakulinen T and Aromaa A: Flavonoid intake and risk of chronic diseases. Am J Clin Nutr 76: 560-568, 2002.
68. Adebamowo CA, Cho E, Sampson L, Katan MB, Spiegelman D, Willett WC and Holmes MD: Dietary flavonols and flavonolrich foods intake and the risk of breast cancer. Int J Cancer 114: 628-633, 2005.
69. Arts IC, Jacobs DR Jr, Gross M, Harnack LJ and Folsom AR: Dietary catechins and cancer incidence among postmenopausal women: the Iowa Womens Health Study (United States). Cancer Causes Control 13: 373-382, 2002
70. Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S and Weiderpass E: Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr 138: 938-945, 2008.
71. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE and Sesso HD: Dietary intake of selected flavonols, flavones, and flavonoidrich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89: 905-912, 2009.
72. Dong JY and Qin LQ: Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125: 315-323, 2011.
73. Velentzis LS, Cantwell MM, Cardwell C, Keshtgar MR, Leathem AJ and Woodside JV: Lignans and breast cancer risk in pre-and post-menopausal women: meta-analyses of observational studies. Br J Cancer 100: 1492-1498, 2009.
74. Buck K, Zaineddin AK, Vrieling A, Linseisen J and Chang-Claude J : Meta-analyses of lignans and enterolignans in relation to breast cancer risk. Am J Clin Nutr 92: 141-153, 2010.
75. Touillaud MS, Thiebaut AC, Fournier A, Niravong M, Boutron-Ruault MC and Clavel-Chapelon F: Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 99: 475-486, 2007.
76. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Olsson H, Adlercreutz H, Landberg G and Wirfält E: Enterolactone is differently associated with estrogen receptor beta-negative and-positive breast cancer in a Swedish nested case-control study. Cancer Epidemiol Biomarkers Prev 17: 3241-3251, 2008.
77. Olsen A, Knudsen KE, Thomsen BL, Loft S, Stripp C, Overvad K, Müller S and Tjøoneland A: Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 13: 2084-2089, 2004.
78. Ward HA, Kuhnle GG, Mulligan AA, Lentjes MA, Luben RN and Khaw KT: Breast, colorectal, and prostate cancer risk in the European Prospective Investigation into Cancer and Nutrition-Norfolk in relation to phytoestrogen intake derived from an improved database. Am J Clin Nutr 91: 440-448, 2010.
79. Zamora-Ros R, Ferrari P, Gonzez CA, Tjøoneland A, Olsen A, Bredsdorff L, Overvad K, Touillaud M, Perquier F, Fagherazzi G, Lukanova A, Tikk K, Aleksandrova K, Boeing H, Trichopoulou A, Trichopoulos D, Dilis V, Masala G, Sieri S, Mattiello A, Tumino R, Ricceri F, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Skeie G, Engeset D, Mendez V, Travier N, Molina-Montes E, Amiano P, Chirlaque MD, Barricarte A, Wallstr P, Sonestedt E, Sund M, Landberg R, Khaw KT, Wareham NJ, Travis RC, Scalbert A, Ward HA, Riboli E and Romieu I: Dietary flavonoid and lignan intake and breast cancer risk according to menopause and hormone receptor status in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Breast Cancer Res Treat 139: 163-117, 2013.
80. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondie UR, Hon B, Casagrande C, Vignat J, Overvad K, Tjøoneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R and Saracci R: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5: 1113-1124, 2002.
81. Adlercreutz H and Mazur W: Phyto-oestrogens and Western diseases. Ann Med 29: 95-120, 1997.
82. Messina M, McCaskill-Stevens W and Lampe JW: Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst 98: 1275-1284, 2006.
83. Webb AL and McCullough ML: Dietary lignans: potential role in cancer prevention. Nutr Cancer 51: 117-131, 2005.
84. Kuiper GG, Carlsson B, Grandien K, Enmark E, Hgblad J, Nilsson S and Gustafsson JA : Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
85. Qin LQ, Xu JY, Wang PY and Hoshi K: Soyfood intake in the prevention of breast cancer risk in women: a meta-analysis of observational epidemiological studies. J Nutr Sci Vitaminol (Tokyo) 52: 428-436, 2006.
86. Wu AH, Yu MC, Tseng CC and Pike MC: Epidemiology of soy exposures and breast cancer risk. Br J Cancer 98: 9-14, 2008.
87. Mourouti N and Panagiotakos DB: Soy food consumption and breast cancer MR. Maturitas 76: 118-122, 2013.
88. Trock BJ, Hilakivi-Clarke L and Clarke R:. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 98: 459-471, 2006.
89. de Lemos ML: Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann Pharmacother 35: 1118-1121, 2001.
90. Magee PJ and Rowland IR: Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr 91: 513-531, 2004.
91. Wada K, Nakamura K, Tamai Y, Tsuji M, Kawachi T, Hori A, Takeyama N, Tanabashi S, Matsushita S, Tokimitsu N and Nagata C: Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int J Cancer 133: 952-960, 2013.
92. Anderson LN, Cotterchio M, Boucher BA, and Kreiger N: Phytoestrogen intake from foods, during adolescence and adulthood, and risk of breast cancer by estrogen and progesterone receptor tumor subgroup among Ontario women. Int J Cancer 132: 1683-1692, 2013.
93. Zaineddin AK, Buck K, Vrieling A, Heinz J, Flesch-Janys D, Linseisen J and Chang-Claude J: The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study. Nutr Cancer 64: 652-665, 2012.
94. Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Kennedy D, Cooley K, Wong R, Sagar S, Sabri E and Fergusson D: Soy, red clover, and isoflavones and breast cancer: a systematic review. PLoS One 8: e81968, 2013.
95. Higdon JV, Delage B, Williams DE and Dashwood RH: Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res 55: 224-236, 2007.
96. Johnson IT: Phytochemicals and cancer. Proc Nutr Soc 66: 207-215, 2007.
97. Cade JE, Burley VJ and Greenwood DC; UK Womens Cohort Study Steering Group: Dietary fibre and risk of breast cancer in the UK Womens Cohort Study. Int J Epidemiol 36: 431-438, 2007
98. Smith-Warner SA, Spiegelman D, Yaun SS, Adami HO, Beeson WL, van den Brandt PA, Folsom AR, Fraser GE, Freudenheim JL, Goldbohm RA, Graham S, Miller AB, Potter JD, Rohan TE, Speizer FE, Toniolo P, Willett WC, Wolk A, Zeleniuch-Jacquotte A and Hunter DJ: Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studies. JAMA 285: 769-776, 2001.
99. Terry P, Jain M, Miller AB, Howe GR and Rohan TE: No association among total dietary fiber, fiber fractions, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 11: 1507-1508, 2002.
100. Suzuki R, Orsini N, Saji S, Key TJ and Wolk A: Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer 124: 698-712, 2009.
101. Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, Inoue M, Krogh V, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Scarmo S, Schairer C, Schouten LJ, Shikany JM, Sieri S, Tsugane S, Visvanathan K, Weiderpass E, Willett WC, Wolk A, Zeleniuch-Jacquotte A, Zhang SM, Zhang X, Ziegler RG and Smith-Warner SA: Fruit and vegetables intake and risk of breast cancer by hormone receptor status. J Natl Cancer Inst 105: 219-236, 2013.
102. Boggs DA, Palmer JR, Wise LA, Spiegelman D, Stampfer MJ, Adams-Campbell LL and Rosenberg L: Fruit and vegetable intake in relation to risk of breast cancer in the Black Womens Health Study. Am J Epidemiol 172: 1268-1279, 2010.
103. Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, Jung S, Khudyakov P, Larsson SC, Lof M, McCullough ML, Miller AB, Neuhouser ML, Palmer JR, Park Y, Robien K, Rohan TE, Ross JA, Schouten LJ, Shikany JM, Tsugane S, Visvanathan K, Weiderpass E, Wolk A, Willett WC, Zhang SM, Ziegler RG and Smith-Warner SA: Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. Am J Clin Nutr 95: 713-725, 2012.
104. Eliassen AH, Hendrickson SJ, Brinton LA, Buring JE, Campos H, Dai Q, Dorgan JF, Franke AA, Gao YT, Goodman MT, Hallmans G, Helzlsouer KJ, Hoffman-Bolton J, Hult K, Sesso HD, Sowell AL, Tamimi RM, Toniolo P, Wilkens LR, Winkvist A, Zeleniuch-Jacquotte A, Zheng W and Hankinson SE: Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies. J Natl Cancer Inst 104: 1905-1916, 2012.
105. Fung TT, Chiuve SE, Willett WC, Hankinson SE, Hu FB and Holmes MD: Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women. Breast Cancer Res Treat 138: 925-930, 2013.
106. Johnson SA and Arjmandi BH: Evidence for anti-cancer properties of blueberries: a mini-review. Anticancer Agents Med Chem 13: 1142-1148, 2013.
107. Masala G, Assedi M, Bendinelli B, Ermini I, Sieri S, Grioni S, Sacerdote C, Ricceri F, Panico S, Mattiello A, Tumino R, Giurdanella MC, Berrino F, Saieva C and Palli D: Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study.Breast Cancer Res Treat 132: 1127-1136, 2012.
108. Tamini RM, Hankinson SE, Campos H, Spiegelman D, Zhang S, Colditz GA, Willett WC and Hunter DJ: Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 161: 153-160, 2005.
109. Adams LS, Phung S, Yee N, Seeram NP, Li L and Chen S: Blueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway. Cancer Res 70: 3594-3605, 2010.
110. Faria A, Pestana D, Teixeira D, de Freitas V, Mateus N and Calhau C: Blueberry anthocyanins and pyruvic acid adducts: anticancer properties in breast cancer cell lines. Phytother Res 24: 1862-1869, 2010.
111. Somassagara RR, Hegde M, Chiruvella KK Musini A, Choudhary B and Raghavan SC: Extracts of strawberry fruits induce intrinsic pathway of apoptosis in breast cancer cells and inhibits tumour progression in mice. PLoS ONE 7: e47021, 2012.
112. Noratto G, Porter W, Byrne D, Cisneros-Zevallos L: Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells. J Agric Food Chem 57: 5219-5226, 2009.
113. Karas M, Amir H, Fishman D, Danilenko M, Segal S, Nahum A, Koifmann A, Giat Y, Levy J, Sharoni Y: Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 36: 101-111, 2000.
114. Gloria NF, Soares N, Brand C, Gloria NF, Soares N, Brand C, Oliveira FL, Borojevic R and Teodoro AJ: Lycopene and betacarotene induce cell-cycle arrest and apoptosis in human breast cancer cell lines. Anticancer Res 34: 1377-1386, 2014.
115. Takeshima M, Ono M, Higuchi T, Chen C, Hara T and Nakano S: Anti-proliferative and apoptosis-inducing activity of lycopene against three subtypes of human breast cancer cell lines. Cancer Sci 105: 252-257, 2014.
116. Dorgan JF, Sowell A, Swanson CA, Potischman N, Miller R and Schussler N and Stephenson HE Jr: Relationships of serum carotenoids, retinol, alpha-tocopherol, and selenium with breast cancer risk: results from a prospective study in Columbia, Missouri (United States). Cancer Causes Control 9: 89-97, 1998.
117. Kabat GC, Kim M, Adams-Campbell LL, Caan BJ, Chlebowski RT, Neuhouser ML, Shikany JM and Rohan TE; WHI Investigators: Longitudinal study of serum carotenoid, retinol, and tocopherol concentrations in relation to breast cancer risk among postmenopausal women. Am J Clin Nutr 90: 162-169, 2009.
118. Hu F, Wang Yi B, Zhang W, Liang J, Lin C, Li D, Wang F, Pang D and Zhao Y: Carotenoids and breast cancer risk: a metaanalysis and meta-regression. Breast Cancer Res Treat 131: 239-253, 2012.
119. Llanos AA, Peng J, Pennell ML, Krok JL, Vitolins MZ, Degraffinreid CR and Paskett ED : Effects of tomato and soy on serum adipokine concentrations in postmenopausal women at increased breast cancer risk: a cross-over dietary intervention trial. J Clin Endocrinol Metab 99: 625-632, 2014.
120. Wang L, Li B, Pan MX, Mo XF, Chen YM and Zhang CX: Specific carotenoid intake is inversely associated with the risk of breast cancer among Chinese women. Br J Nutr 111: 1686-1695, 2014.
121. Tamimi RM, Colditz GA and Hankinson SE: Circulating carotenoids, mammographic density, and subsequent risk of breast cancer. Cancer Res 69: 9323-9329, 2009.
122. Voskuil DW, Vrieling A, Korse CM, Beijnen JH, Bonfrer JM, van Doorn J, Kaas R, Oldenburg HS, Russell NS, Rutgers EJ, Verhoef S, van Leeuwen FE, vant Veer LJ and Rookus MA: Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk. Nutr Cancer 60: 342-353, 2008.
123. Dusso AS, Brown AJ and Slatopolsky E: Vitamin D. Am J Physiol RenalPhysiol 289: F8
124. Colston KW and Hansen CM: Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocrine-Related Cancer 9: 45-59, 2002.
125. Cui Y and Rohan TE: Vitamin D, calcium, and breast cancer risk: a review.Cancer Epidemiol Biomarkers Prev 15: 1427-1437, 2006.
126. Welsh J: Vitamin D and prevention of breast cancer. Acta Pharmacol Sin 28: 1373-1382, 2007.
127. John EM, Schwartz GG, Dreon DM and Koo J: Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev 8: 399-406, 1999.
128. Chen P, Hu P, Xie D, Qin Y, Wang F and Wang H : Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121: 469-477, 2010.
129. Gissel T, Rejnmark L, Mosekilde L and Vestergaard P: Intake of vitamin D and risk of breast cancer-a meta-analysis. J Steroid Biochem Mol Biol 111: 195-199, 2008.
130. Lappe J, Cullen D, Haynatzki G, Recker R, Ahlf R and Thompson K: Calcium and vitamin d supplementation decreases incidence of stress fractures in female navy recruits. J Bone Miner Res 23: 741-749, 2008.
131. Anderson LN, Cotterchio M, Vieth R and Knight JA: Vitamin D and calcium intakes and breast cancer risk in pre-and postmenopausal women. Am J Clin Nutr 91: 1699-1707, 2010.
132. Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T and Trikalinos TA: Vitamin D and calcium: a systematic review of health outcomes. Evid Rep Technol Assess 183: 1-420, 2009.
133. Abbas S, Linseisen J, Rohrmann S, Chang-Claude J, Peeters PH, Engel P, Brustad M, Lund E, Skeie G, Olsen A, Tjøoneland A, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Fagherazzi G, Kaaks R, Boeing H, Buijsse B, Adarakis G, Ouranos V, Trichopoulou A, Masala G, Krogh V, Mattiello A, Tumino R, Sacerdote C, Buckland G, Suáez MV, Sánchez MJ, Chirlaque MD, Barricarte A, Amiano P, Manjer J, Wirfält E, Lenner P, Sund M, Bueno-de-Mesquita HB, van Duijnhoven FJ, Khaw KT, Wareham N, Key TJ, Fedirko V, Romieu I, Gallo V, Norat T, Wark PA and Riboli E: Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Nutr Cancer 65: 178-187, 2013.
134. Engel P, Fagherazzi G, Boutten A, DuprT, Mesrine S, Boutron-Ruault MC and Clavel-Chapelon F: Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 19: 2341-2350, 2010.
135. Yin L, Grandi N, Raum E, Haug U, Arndt V and Brenner H: Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 46: 2196-2205, 2010.
136. Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC and Hankinson SE: Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses Health Study II. Breast Cancer Res 13: R50, 2011.
137. Mohr SB, Gorham ED, Alcaraz JE, Kane CJ, Macera CA, Parsons JK, Wingard DL and Garland CF: Serum 25-hydroxyvitamin D and prevention of breast cancer: pooled analysis. Anticancer Res 31: 2939-2948, 2011.
138. Amir E, Cecchini RS, Ganz PA, Costantino JP, Beddows S, Hood N and Goodwin PJ: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1. Breast Cancer Res Treat 133: 1077-1088, 2012.
139. Kün T, Kaaks R, Becker S, Eomois PP, Clavel-Chapelon F, Kvaskoff M, Dossus L, Tjøoneland A, Olsen A, Overvad K, Chang-Claude J, Lukanova A, Buijsse B, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Krogh V, Sacerdote C, Tumino R, Mattiello A, Buckland G, Sánchez MJ, Menédez V, Chirlaque MD, Barricarte A, Bueno-de-Mesquita HB, van Duijnhoven FJ, van Gils CH, Bakker MF, Weiderpass E, Skeie G, Brustad M, Andersson A, Sund M, Wareham N, Khaw KT, Travis RC, Schmidt JA, Rinaldi S, Romieu I, Gallo V, Murphy N, Riboli E and Linseisen J: Plasma 25-hydroxyvitamin D and the risk of breast cancer in the European prospective investigation into cancer and nutrition: A nested case-control study. Int J Cancer 133: 1689-1700, 2013.
140. Bauer SR, Hankinson SE, Bertone-Johnson ER and Ding EL: Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92: 123-131, 2013.
141. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007.
142. Lappe J, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 85: 1586-1591, 2007.
143. Avenell A, ManLennan G, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ and Wallace WA; RECORD Trial Group: Longterm follow-up for mortality and cancer in a randomized placebocontrolled trial of vitamin D(3) and/or calcium (RECORD trial). J Clin Endocrinol Metab 97: 614-622, 2012.
144. Sperati F, Vici P, Maugeri-SaccM, Stranges S, Santesso N, Mariani L, Giordano A, Sergi D, Pizzuti L, Di Lauro L, Montella M, Crispo A, Mottolese M and Barba M: Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials. PLoS One 8: e69269, 2013.
145. Li M, Chen P, Li J, Xie D and Wang H: Review: The Impacts of Circulating 25-Hydroxyvitamin D Levels on Cancer Patient Outcomes: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 99: 2327-2336, 2014.
146. Kim Y and Je Y: Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis. Br J Cancer 110: 2772-2784, 2014.
147. Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW and Jäättelä M: Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 277: 30738-30745, 2002.
148. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, OSullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J and Hubbell FA; Womens Health Initiative Investigators: Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 100: 1581-1591, 2008.
149. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D and Hershman DL: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27: 2151-2156, 2009.
150. Greenwald P, Anderson D, Nelson SA and Taylor PR: Clinical trials of vitamin and mineral supplements for cancer prevention. Am J Clin Nutr 85: 314S-317S, 2007.
151. Nagel G, Linseisen J, van Gils CH, Peeters PH, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I, Tjøoneland A, Olsen A, Roswall N, Witt PM, Overvad K, Rohrmann S, Kaaks R, Drogan D, Boeing H, Trichopoulou A, Stratigakou V, Zylis D, Engeset D, Lund E, Skeie G, Berrino F, Grioni S, Mattiello A, Masala G, Tumino R, Zanetti R, Ros MM, Bueno-de-Mesquita HB, Ardanaz E, Sánchez MJ, Huerta JM, Amiano P, Rodruez L, Manjer J, Wirfält E, Lenner P, Hallmans G, Spencer EA, Key TJ, Bingham S, Khaw KT, Rinaldi S, Slimani N, Boffetta P, Gallo V, Norat T and Riboli E: Dietary beta-carotene, vitamin C and E intake and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Breast Cancer Res Treat 119: 753-765, 2010.
152. Paski SC and Xu Z: Growth factor stimulated cell proliferation is accompanied by an elevated labile intracellular pool of zinc in 3T3 cells. Can J Physiol. Pharmacol 80: 790-795, 2002.
153. Haase H and Rink L: Zinc signals and immune function. Biofactors 40: 27-40, 2014.
154. Pan SY, Zhou J, Gibbons L, Morrison H and Wen SW; Canadian Cancer Registries Epidemiology Research Group [CCRERG]: Antioxidants and breast cancer risk-A population-based casecontrol study in Canada. BMC Cancer 11: 372, 2011.
155. Pierpaoli E, Viola V, Barucca A, Orlando F, Galli F and Provinciali M: Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice. Carcinogenesis 34: 1352-1360, 2013.
156. Ahn KS, Sethi G, Krishnan K and Aggarwal BB: et al. c-Tocotrienol inhibits nuclear factor-jb signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J. Biol.Chem 282: 809-820, 2007.
157. Loganathan R, Selvaduray KR, Nesaretnam K and Radhakrishnan AK: Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity. Cell Prolif 46: 203-213, 2013.
158. Kim YI: Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 13: 511-519, 2004.
159. Larsson SC, Giovannucci E and Wolk A: Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99: 64-76, 2007.
160. Lewis SJ, Harbord RM, Harris R and Smith GD: Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 98: 1607-1622, 2006.
161. Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R and Tsugane S: Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 61: 447-456, 2009.
162. Maruti SS, Ulrich CM and White E: Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr 89: 624-633, 2009.
163. Shrubsole MJ, Shu XO, Li HL, Cai H, Yang G, Gao YT, Gao J and Zheng W: Dietary B vitamin and methionine intakes and breast cancer risk among Chinese women. Am J Epidemiol 173: 1171-1182, 2011.
164. Bassett JK, Baglietto L, Hodge AM, Severi G, Hopper JL, English DR and Giles GG: Dietary intake of B vitamins and methionine and breast cancer risk. Cancer Causes Control 24: 1555-1563, 2013.
165. Yang D, Baumgartner RN, Slattery ML, Wang C, Giuliano AR, Murtaugh MA, Risendal BC, Byers T and Baumgartner KB: Dietary intake of folate, B-vitamins and methionine and breast cancer risk among Hispanic and non-Hispanic white women. PLoS One 8: e54495, 2013.
166. Weiwei Z, Liping C and Dequan L: Association between dietary intake of folate, vitamin B6, B12 & MTHFR, MTR Genotype and breast cancer risk Pak J Med Sci 30: 106-110, 2014.
167. Ma E, Iwasaki M, Kobayashi M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R and Tsugane S: Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Japan. Nutr Cancer 61: 447-456, 2009.
168. Lin J, Lee IM, Cook NR, Selhub J, Manson JE, Buring JE and Zhang SM: Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr 87: 734-743, 2008.
169. Singletary KW and Gapstur SM: Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 286: 2143-2151, 2001.
170. Smith-Warner SA, Spiegelman D, Yaun SS, van den Brandt PA, Folsom AR, Goldbohm RA, Graham S, Holmberg L, Howe GR, Marshall JR, Miller AB, Potter JD, Speizer FE, Willett WC, Wolk A and Hunter DJ: Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA 279: 535-540, 1998.
171. Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X, Haile RW, Boice JD Jr; WECARE Study Collaborative Group and Bernstein JL: Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Womens Environmental Cancer and Radiation Epidemiology Study. Am J Epidemiol 169: 962-968, 2009.
172. Dumitrescu RG and PG Shields: The etiology of alcohol-induced breast cancer. Alcohol 35: 213-225, 2005.
173. Halsted CH, Villanueva JA, Devlin AM and Chandler CJ: Metabolic interactions of alcohol and folate. J Nutr 132: 2367S-2372S, 2002.
174. Gao CM, Ding JH, Li SP, Liu YT, Qian Y, Chang J, Tang JH and Tajima K: Active and passive smoking, and alcohol drinking and breast cancer risk in chinese women. Asian Pac J Cancer Prev 14: 993-996, 2013.
175. Fagherazzi G, Vilier A, Boutron-Ruault MC, Mesrine S and Clavel-Chapelon F : Alcohol consumption and breast cancer risk subtypes in the E3N-EPIC cohort. Eur J Cancer Prev. 2014 Apr 16. [Epub ahead of print].